GOLDSTEIN JOSEPH L 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Sep 13, 2021
Insider Transaction Report
Form 4
GOLDSTEIN JOSEPH L
Director
Transactions
- Sale
Common Stock
2021-09-10$650.00/sh−2,479$1,611,350→ 5,891 total - Exercise/Conversion
Common Stock
2021-09-10$380.95/sh+2,479$944,375→ 8,370 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-09-10−2,479→ 0 totalExercise: $380.95Exp: 2028-01-02→ Common Stock (2,479 underlying)
Footnotes (2)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- [F2]The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.